Company Monitoring Page for Pfizer

latest headlines for company on cafepharma

Pfizer's off the hook after federal judge dismisses proposed lawsuit over Chantix recalls
Endpoints
Thu, 02/17/22 - 11:14 pm
Tags:
Pfizer, legal, Chantix, class action lawsuits, product recalls
Covid infects biopharma’s biggest sellers
EP Vantage
Thu, 02/17/22 - 10:45 am
Tags:
Pfizer, AstraZeneca, vaccines, COVID-19, Roche
2 Reasons Why Pfizer Might Crush Moderna in the mRNA Market. And 1 Reason Why Moderna May Stay Ahead.
Motley Fool
Thu, 02/17/22 - 10:40 am
Tags:
Pfizer, Moderna Therapeutics, MRNA, vaccines
Worried About Pfizer's Post-Pandemic Growth? These 14 Words from Pfizer's CEO Should Reassure You.
Motley Fool
Wed, 02/16/22 - 10:46 am
Tags:
Pfizer, Pharma CEOs, Albert Bourla, pandemic, vaccines, COVID-19
With FDA nods and third-shot OKs, Moderna and Pfizer boost vaccine ads – and booster messages
Endpoints
Tue, 02/15/22 - 11:24 pm
Tags:
Moderna Therapeutics, Pfizer, BioNTech, COVID-19, vaccines, pharma marketing, DTC advertising
Pfizer stalls COVID-19 vaccine app as it awaits data on third dose in young kids
Fierce Pharma
Sat, 02/12/22 - 11:58 pm
Tags:
Pfizer, COVID-19, vaccines, clinical trials, pediatric
Breaking Down Pfizer and Moderna's Omicron-Specific Vaccine Trials
Motley Fool
Sat, 02/12/22 - 11:54 pm
Tags:
Pfizer, Moderna Therapeutics, clinical trials, vaccines, COVID-19, Omicron COVID-19 variant
Pfizer aims to restart late-stage trial of Duchenne gene therapy following safety setback
BioPharma Dive
Thu, 02/10/22 - 08:04 pm
Tags:
Pfizer, gene therapy, Duchenne Muscular Dystrophy, clinical trials
Pfizer’s $100bn question
EP Vantage
Thu, 02/10/22 - 10:14 am
Tags:
Pfizer, COVID-19, earnings
Pfizer, in a rare COVID-19 setback, dumps Paxlovid's intravenous sibling in further blow to ACTIV-3
Fierce Biotech
Wed, 02/9/22 - 10:08 am
Tags:
Pfizer, ACTIV-3, COVID-19, Paxlovid, PF-07304814
Pfizer's Covid-19 vaccine captures the most annual sales of any medical product ever — by more than $15B
Endpoints
Tue, 02/8/22 - 10:12 am
Tags:
Pfizer, COVID-19, vaccines, drug sales, earnings
Pfizer's $130M Lyme disease vaccine advances to phase 3 after 3rd shot shown to increase antibodies
Fierce Biotech
Fri, 02/4/22 - 11:06 am
Tags:
Pfizer, Valneva, vaccines, Lyme disease, clinical trials, VLA15
How Concerning Is Pfizer and Opko's Latest FDA Rejection?
Motley Fool
Thu, 02/3/22 - 11:11 pm
Tags:
Pfizer, OPKO Health, FDA, somatrogon
Pfizer accuses former employees of 'treachery' in stealing trade secrets to form Regor Therapeutics
Fierce Biotech
Thu, 02/3/22 - 10:34 am
Tags:
Pfizer, diabetes, obesity, legal, trade secrets
Baker's dozen: Pfizer joins 12 peers in restricting sales of discounted drugs under a federal program
Endpoints
Tue, 02/1/22 - 11:31 pm
Tags:
Pfizer, 340B, drug discounts
Feds' contract with Pfizer for Paxlovid has some surprises
NPR
Tue, 02/1/22 - 11:29 pm
Tags:
Pfizer, COVID-19, Paxlovid, government contract
Digital collaboration here to stay beyond pandemic for Merck, Pfizer, others
MedCity News
Tue, 02/1/22 - 10:29 am
Tags:
digital pharma, pandemic, COVID-19, Merck, Pfizer, virtual meetings
Pfizer ends $3B drug dream despite phase 2b success, leaving Regeneron with a clear run at cardiovascular market
Fierce Biotech
Mon, 01/31/22 - 10:47 am
Tags:
Pfizer, vupanorsen, Ionis Pharmaceuticals, cholesterol
EC criticised in probe of COVID vaccine texts with Pfizer CEO
Pharmaforum
Fri, 01/28/22 - 10:23 am
Tags:
Pfizer, Albert Bourla, Europe, vaccines, COVID-19, Pharma CEOs
Is Pfizer About to Have Another Megablockbuster Drug in Its Lineup?
Motley Fool
Fri, 01/28/22 - 10:17 am
Tags:
Pfizer, abrocitinib, atopic dermatitis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.